Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid and drug overdose crisis. Our publications and webinars include the recommendations of experts and the perspectives of those on the frontlines.

COVID-19 Response

DEA: Narcotic Treatment Programs Exception to 21 CFR 1301.74(i)

March 16, 2020
The Drug Enforcement Administration (DEA) has granted narcotic treatment programs (NTPs) an exception to 21 CFR 1301.74(i) in orde...

COVID-19 Response

Webinar: Federal and State Policy Levers to Maintain Access to MOUD During the COVID-19 Pandemic

March 26, 2020
Join Jocelyn Guyer, MPA, and Jodi Manz, MSW, as they review emerging federal and state actions and opportunities (including case s...

COVID-19 Response

Harvard Law, Bill of Health: Protecting the Vulnerable SUD Population During COVID-19

March 26, 2020
Details concerning the additional challenges faced by the SUD (and OUD) population at this time, the positive ameliorative steps t...

COVID-19 Response

SAMHSA: FAQ on the provision of methadone and buprenorphine for the treatment of OUD in the COVID-19 Emergency

March 19, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled an FAQ on prescribing MOUD during the COVID-19...

COVID-19 Response

Webinar: MOUD and the COVID-19 National Emergency Response

March 19, 2020
Join Dr. Hannah Snyder, Jodi Manz, MSW, and Daniel McClughen, Esq. as they review key steps, fast evolving regulatory changes, and...

COVID-19 Response

SAMHSA: COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance

March 19, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) is providing guidance to ensure that SUD treatment services...